Medtronic plc — Director's Dealing 2016

Sep 28, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Medtronic plc (MDT)
CIK: 0001613103
Period of Report: 2016-09-26

Reporting Person: Kuntz Richard (SrVP & Chief Scien, Clin, Reg)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-09-26	Ordinary Shares	M	30624	$35.92	Acquired	149425	Direct
2016-09-26	Ordinary Shares	S	25199	$86.67	Disposed	124226	Direct
2016-09-27	Ordinary Shares	S	17141	$86.696	Disposed	107085	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-09-26	Stock Option (Right to Buy)	$35.92	M	30624	Disposed	2019-08-03	Ordinary Shares (30624)	Direct

Footnotes

F1: The price is a weighted average price. These shares were sold in multiple transactions in prices ranging from $86.57 to $86.735, inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote in this Form 4.

F2: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $86.675 to $86.725, inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3: This option to purchase 30,624 New Medtronic ordinary shares for $35.92 per share, which was fully vested at the effective time of the Merger, was received in the Merger and represents the conversion of 30,624 Medtronic common stock shares for $35.92 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.